Active	Status	Sponsor type	Region	Phase	Filter
12 Active 6 Inactive 18 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
FAIN, Olivier
FaCIL-2, NCT03970954: Low-dose Interleukin-2 in Women With Unexplained Miscarriages	Completed	1/2	18	Europe	low-dose IL-2, interleukin-2	Assistance Publique - Hôpitaux de Paris, Iltoo Pharma	Recurrent Miscarriage	07/23	03/24
NCT01034969: Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)	Recruiting	N/A	3000	Europe, RoW		Shire, Takeda Development Center Americas, Inc.	Hereditary Angioedema (HAE)	01/27	01/27
Mekinian, Arsene
TOCIAION, NCT04239196: Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA	Recruiting	2	58	Europe	tocilizumab and IV steroids combination, IV steroids combination alone	Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Roche Chugai	Giant Cell Arteritis, Optic Ischaemic Neuropathy	11/20	12/22
FaCIL-2, NCT03970954: Low-dose Interleukin-2 in Women With Unexplained Miscarriages	Completed	1/2	18	Europe	low-dose IL-2, interleukin-2	Assistance Publique - Hôpitaux de Paris, Iltoo Pharma	Recurrent Miscarriage	07/23	03/24
Lorenzon, Roberta
DF-IL2-REP, NCT05153070: Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes	Recruiting	2	24	Europe	Cyclosporin, ILT101, Placebo	Assistance Publique - Hôpitaux de Paris, Iltoo Pharma	Type 1 Diabetes	10/24	07/26
FaCIL-2, NCT03970954: Low-dose Interleukin-2 in Women With Unexplained Miscarriages	Completed	1/2	18	Europe	low-dose IL-2, interleukin-2	Assistance Publique - Hôpitaux de Paris, Iltoo Pharma	Recurrent Miscarriage	07/23	03/24